Annotation Detail for GREB1L
Basic Information
Top
| Gene Symbol: | GREB1L ( C18orf6,KIAA1772 ) |
|---|
| Gene Full Name: | growth regulation by estrogen in breast cancer-like |
|---|
| Band: | 18q11.1-q11.2 |
|---|
| Quick Links | Entrez ID:80000; OMIM: NA; Uniprot ID:GRB1L_HUMAN; ENSEMBL ID: ENSG00000141449; HGNC ID: 31042 |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of GREB1L mRNA] | affects expression|affects reaction | 19414516
|
| C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of GREB1L mRNA] | affects expression|affects reaction | 19414516
|
| D000242 |
Cyclic AMP |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of GREB1L mRNA] | affects expression|affects reaction | 19414516
|
| D014212 |
Tretinoin |
Tretinoin results in increased expression of GREB1L mRNA | increases expression | 15688020
16038797
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.98 | 15955085 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.32 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.34 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.44 | 16456186 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.99 | 16935849 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
4.09 | 16197459 16206674 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.23 | 16873071 16443354 16166294 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.33 | 16813970 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
6.03 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.92 | 1917145 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.38 | 16051514 16096774 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
3.32 | 17460283 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.33 | 16129372 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
6.03 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.81 | 9407595 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
4.35 | 17035595 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 9664655 10589399 9125849 16925845 9224671 17551590 8800419 14991402 9142499 9211117 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
5.33 | 18230668 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.37 | 16569247 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.90 | 9664655 16938888 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
4.16 | 17994277 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.27 | 17312396 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.46 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
6.03 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.09 | 9664655 14991402 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.57 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
5.22 | 16778211 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.42 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.39 | 17551590 15992940 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
2.95 | 17143497 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.18 | 16482212 19285840 16932348 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.13 | 17596541 16294345 19850784 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.42 | 16766008 16891316 16140955 19642359 19029980 17361223 15748426 9834237 17301526 16788101 16331271 17649720 16935935 16823087 19225113 12679006 17368321 17506722 17217047 17339181 19035177 17294898 17107899 19075265 17712046 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.62 | 9224671 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 16248980 18397230 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.92 | 17453147 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
1.99 | 16752155 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
5.08 | 16940565 |
| MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
5.74 | 11304026 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.30 | 17596541 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.59 | 16594593 16946489 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.36 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.32 | 9142499 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.45 | 16936753 |
| MESH:D010146 |
Pain |
|
Tretinoin |
3.28 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.58 | 15976015 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
4.13 | 16636307 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
5.54 | 16723453 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.63 | 16116481 16283617 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.78 | 16467112 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.36 | 17045167 16026305 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.24 | 16051514 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.47 | 16040207 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
4.12 | 16129372 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.48 | 16752155 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.64 | 16761959 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.39 | 16287080 |
Related Pathway Information